The Structure of Phosphorylated GSK-3β Complexed with a Peptide, FRATtide, that Inhibits β-Catenin Phosphorylation
- 31 December 2001
- journal article
- Published by Elsevier BV in Structure
- Vol. 9 (12), 1143-1152
- https://doi.org/10.1016/s0969-2126(01)00679-7
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- GSK‐3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β‐catenin stabilisation without elevation of glycogen synthase activityFEBS Letters, 2001
- Wnt Signaling in Oncogenesis and Embryogenesis--a Look Outside the NucleusScience, 2000
- Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathwaysOncogene, 1999
- A GSK3‐binding peptide from FRAT1 selectively inhibits the GSK3‐catalysed phosphorylation of Axin and β‐cateninFEBS Letters, 1999
- The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transductionPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1999
- Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3βCurrent Biology, 1998
- Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase‐3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulinFEBS Letters, 1998
- Activation Mechanism of the MAP Kinase ERK2 by Dual PhosphorylationCell, 1997
- Tyrosine dephosphorylation of glycogen synthase kinase‐3 is involved in its extracellular signal‐dependent inactivationFEBS Letters, 1996
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995